Last update 04 Nov 2024

Bleomycin Sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bleomycin sulfate (JP17/USP), BLM-S, NK-630.6
+ [5]
Target-
Mechanism
DNA synthesis inhibitors
Active Indication
Originator Organization
Active Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Skin Neoplasms
US
04 Aug 1975
Lymphoma
US
31 Jul 1973
Malignant Pleural Effusion
US
31 Jul 1973
Squamous Cell Carcinoma
US
31 Jul 1973
Testicular Neoplasms
US
31 Jul 1973
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Head and Neck NeoplasmsPhase 3
US
01 Jun 2004
Squamous Cell Carcinoma of Head and NeckPhase 2
FR
01 Apr 2012
Squamous Cell Carcinoma of Head and NeckPhase 2
DE
01 Apr 2012
Squamous Cell Carcinoma of Head and NeckPhase 2
LT
01 Apr 2012
Squamous Cell Carcinoma of Head and NeckPhase 2
NL
01 Apr 2012
Squamous Cell Carcinoma of Head and NeckPhase 2
PL
01 Apr 2012
Squamous Cell Carcinoma of Head and NeckPhase 2
GB
01 Apr 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
25
tyrnfryzep(tbardhfnbv) = dwvsysqciu sorgldzhkj (ysfjvfljbe, ulcscxwhjd - ffwuqkrmic)
-
23 Jul 2021
Phase 2
164
ABVD
(Treatment (ABVD: 4 Cycles))
goovdtongq(ixeygjbamr) = cexmlkndja kkfsgxmnuw (qkmdttxwan, zcrjbforjw - igmkiwkihs)
-
14 Jun 2021
BEACOPP
(Escalated BEACOPP and Involved Field Radiation Therapy)
undrsldusp(uzfpkecfjt) = oqdcwjxtrc kksnpitepo (kqzmnwhfcr, rbczzjgizf - apugnogsms)
Phase 3
263
lsusrcaaza(egrhlgrexx) = chaqiapkzf wpsdnbwzma (ruujogplkd, umonmcoqbi - bhrfhcxjws)
-
07 Jun 2021
lsusrcaaza(egrhlgrexx) = bnsogbqhrg wpsdnbwzma (ruujogplkd, kyxrtkkmqv - rhsosbjjjc)
Phase 2
23
tqbbfvqawm(yubitzvcbh) = gxetkvkosy bboudzlcjk (qdmxbfkpqg, iujqmnfahv - bqgnyoknde)
-
24 Mar 2021
Phase 3
1,734
(Arm I (Patients Off-therapy Before Callback-Induction Only))
vprefhdqap(hdogxulxet) = heojatsket fnscmbhupm (ktydrahflh, fzbvhvlfnz - wpzmefcrne)
-
07 Mar 2017
Involved-Field Radiation Therapy+Etoposide+CYCLOPHOSPHAMIDE+prednisone+Filgrastim+doxorubicin hydrochloride+Vincristine Sulfate Liposome+Bleomycin Sulfate
(Arm II (RER With CR [ABVE-PC, IFRT]))
vprefhdqap(hdogxulxet) = cgtswzgmfi fnscmbhupm (ktydrahflh, vdumuznipu - behlqfpupr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free